United States - English - NLM (National Library of Medicine)

hahnemann laboratories, inc. - yttrium iodide (unii: iwj2y80d1j) (yttrium iodide - unii:iwj2y80d1j) -

United States - English - NLM (National Library of Medicine)

hahnemann laboratories, inc. - yttrium oxide (unii: x8071685xt) (yttrium oxide - unii:x8071685xt) -

United States - English - NLM (National Library of Medicine)

hahnemann laboratories, inc. - yttrium chloride (unii: 11521xld38) (yttrium cation - unii:1fyp74lm4p) -

Ireland - English - HPRA (Health Products Regulatory Authority)

ge healthcare limited - yttrium (90 y) silicate - suspension for injection - 37-92.5 mb mbq/ml

Israel - English - Ministry of Health

isotopia molecular imaging, israel - yttrium (90y) chloride - solution for injection - yttrium (90y) chloride 1850 mbq - yttrium (90-y) compounds - ytracis is indicated to be used only for the radiolabelling of carrier molecules which have been specifically developed and authorized for radiolabelling with this radionuclide. radiopharmaceutical precursor - not intended for direct application to patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

boston scientific pty ltd - 38303 - radionuclide source, therapeutic, brachytherapy, manual, permanent implant - therasphere is a low toxicity, targeted liver cancer therapy made of insoluble glass beads containing radioactive yttrium-90 (y-90). the mean sphere diameter ranges from 20-30 micrometers with 22,000-73,000 microspheres per mg dose dispersed in pyrogen-free water. y-90 is a pure beta emitter and mean tissue penetration is 2.5-11mm. most of the radiation is delivered to the tumour in the first two weeks after treatment. custom dose sizes are available in 0.5gbq increments between 3-20gbq. therasphere is used in the treatment of hepatic malignancies.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - pendimethalin(440g/l)+trifluralin(480g/l)+dicamba as dma(500g/l) + others - unspecified class

Australia - English - Department of Health (Therapeutic Goods Administration)

boston scientific pty ltd - 38303 - radionuclide source, therapeutic, brachytherapy, manual, permanent implant - therasphere is a low toxicity, targeted liver cancer therapy made of insoluble glass beads containing radioactive yttrium-90 (y-90). the mean sphere diameter ranges from 20-30 micrometers with 22,000-73,000 microspheres per mg dose dispersed in pyrogen-free water. y-90 is a pure beta emitter and mean tissue penetration is 2.5-11mm. most of the radiation is delivered to the tumour in the first two weeks after treatment. custom dose sizes are available in 0.5gbq increments between 3-20gbq. therasphere is used in the treatment of hepatic malignancies.

United States - English - NLM (National Library of Medicine)

hahnemann laboratories, inc. dba alpine pharmaceuticals - yttrium fluoride (unii: v8qs7wes60) (yttrium fluoride - unii:v8qs7wes60) - colds use according to standard homeopathic indications for self-limiting conditions, such as listed above. colds

United States - English - NLM (National Library of Medicine)

hahnemann laboratories, inc. dba alpine pharmaceuticals - yttrium bromide (unii: d60qt594zj) (yttrium bromide - unii:d60qt594zj) - colds use according to standard homeopathic indications for self-limiting conditions, such as listed above.  colds